HRI reiterates warning against use of unlicensed herbal remedies

You may have read the story in the Mail on Sunday on 28th October about a woman who is believed to have suffered liver failure following the use of an unlicensed product containing the traditional herbal medicine, Black Cohosh, which is traditionally used to relieve the symptoms of menopause.

Terry Gallagher of HRI Herbal medicine commented, “At HRI Herbal medicines we are working hard to stop tragedies like this by making consumers aware of the risks associated with using unlicenced alternative traditional remedies. It only takes a second to check whether the products people choose carry the Traditional Herbal Registration (THR) logo and / or a Product Licence (PL) number showing it is regulated by the national regulator, the Medicines and Healthcare products Regulatory Authority (MHRA).

“Reputable suppliers like HRI Herbal Medicines only supply approved  products that meet the stringent standards set by the MHRA. The regulator not only controls crucial aspects such as the dosage and quality of the active medicinal ingredient in each tablet, but also the stability of the medicine over time and the quality of patient information. Every licenced product comes with a clear patient leaflet which explains about any potential side-effects and contra-indications about taking the remedy with other medicines – traditional or otherwise – or which health conditions mean the product may not be suitable.”

HRI is a member of  British Herbal Medicine Association ( ) and the Health Food Manufacturers’ Association ( and all its products are regulated by the MHRA and carry an approved product licence number.